Volpara Health Technologies (ASX: VHT) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Volpara Health Technologies Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Volpara Health Technologies (ASX: VHT)
Latest News
Speculative
3 exciting small cap ASX shares to put on your watchlist immediately
Share Market News
ASX 200 down 0.4%, Credit Corp and Temple & Webster impress
Speculative
4 top small cap ASX shares to watch in FY 2021
Share Market News
Why these ASX tech shares should be on your radar
Speculative
Why you should watch these exciting small cap ASX healthcare shares closely
⏸️ ASX Shares
10 more top broker ASX share picks for FY21
⏸️ TMF AMP
Top ASX Stock Picks for July 2020
Speculative
Are these small cap ASX tech shares the next Afterpay or Appen?
Speculative
3 exciting small cap ASX healthcare shares to watch
Speculative
3 exciting small cap ASX shares to watch closely in the 2020s
⏸️ ASX Shares
3 great shares to buy now if you're an ASX 200 investor in your 20s
Speculative
5 exciting small cap ASX shares to watch in June
Frequently Asked Questions
-
No, the ASX healthcare share has not yet paid any dividends.
-
Volpara listed on 27 April 2016.
VHT ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Volpara Health Technologies
Volpara Health Technologies Ltd (ASX: VHT) is a small but growing research, development, and manufacturing company that provides breast screening technology and risk analysis for patients and medical professionals.
Volpara’s artificial intelligence-powered software for early detection of breast cancer is used by more than 2,000 facilities and more than 5,600 mammography technologists, impacting nearly 15 million patients globally. Volpara is based in Wellington, New Zealand, and also has a US office in Seattle.
Volpara Health Technologies Ltd (ASX: VHT) was removed from the ASX Official List on 22 May 2024.